Cypress Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$245K Hold
1,288
0.28% 66
2018
Q4
$251K Hold
1,288
0.34% 63
2018
Q3
$267K Hold
1,288
0.28% 68
2018
Q2
$238K Hold
1,288
0.26% 72
2018
Q1
$220K Sell
1,288
-20
-2% -$3.67K 0.24% 73
2017
Q4
$227K Buy
1,308
+20
+2% +$3.54K 0.22% 76
2017
Q3
$240K Sell
1,288
-87
-6% -$15.4K 0.39% 52
2017
Q2
$237K Sell
1,375
-1,272
-48% -$207K 0.28% 66
2017
Q1
$434K Sell
2,647
-49
-2% -$8.14K 0.2% 107
2016
Q4
$394K Buy
2,696
+56
+2% +$8.43K 0.18% 113
2016
Q3
$440K Buy
2,640
+288
+12% +$48.7K 0.2% 106
2016
Q2
$358K Buy
2,352
+83
+4% +$12.9K 0.18% 113
2016
Q1
$340K Sell
2,269
-18
-0.8% -$2.67K 0.16% 121
2015
Q4
$371K Buy
2,287
+50
+2% +$7.86K 0.19% 109
2015
Q3
$309K Buy
2,237
+753
+51% +$119K 0.17% 123
2015
Q2
$228K Buy
+1,484
New +$238K 0.13% 129

Other funds holding AMGN

Cypress Wealth Advisors's AMGN Position: Q1 2019 in Review

Cypress Wealth Advisors held its Amgen (AMGN) position steady in Q1 2019 at 1,288 shares worth $245K. The position accounts for 0.28% of the portfolio, ranked #66.

Cypress Wealth Advisors first reported a position in AMGN in Q2 2015 and has held it in 16 quarters since. The position peaked at $440K in Q3 2016. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Cypress Wealth Advisors held 1,288 shares of Amgen worth $245K as of Q1 2019.
  • Cypress Wealth Advisors left its Amgen share count unchanged in Q1 2019.
  • Amgen made up 0.28% of Cypress Wealth Advisors's portfolio in Q1 2019, its #66 holding.
  • Cypress Wealth Advisors first reported a position in Amgen in Q2 2015 and has held it in 16 quarters since.
  • Cypress Wealth Advisors's Amgen position peaked at $440K in Q3 2016.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Cypress Wealth Advisors's 13F filing for Q1 2019, filed 17 May 2019.